HK-listed New Horizon posts best session on robust earnings outlook

New Horizon Health

17/01/2022 06:05

** Shares of New Horizon Health Ltd  6606.HK  jump as much
as 39.3% to HK$29.25, their biggest intraday percentage gain
since debut on Feb 18
    ** Stock of the cancer screening products developer hits the
highest since Dec 1, on track for a second session of gains;
biggest percentage gainer in Hang Seng Composite Index  .HSCI 
and the sixth-biggest on the Hong Kong bourse
    ** The Zhejiang, China-based co expects its 2021 gross
profit to jump 294.6%-324.2% from 2020, and total revenue to
surge 190.8%-207.8%, due to higher revenue and gross profit of
its products ColoClear and Pupu Tube  urn:newsml:reuters.com:*:nFWN2TT1CJ
    ** The Hang Seng Commerce & Industry Index  .HSNC  falls
1.2% and healthcare index  .HSCIH  drops 1.5%
    ** The Hang Seng Composite Index  .HSCI  eases 1.1% and the
benchmark Hang Seng Index  .HSI  slips 1%
    

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))